Abiomed, a specialist in breakthrough heart support and recovery technologies, announced it has accepted the resignation of its CFO, Michael Tomsicek. After two years, Tomsicek is leaving the Company to pursue other interests.
While the Company performs its external search to identify a replacement for Tomsicek, the Company's former CFO, Robert Bowen, will return from retirement to support the organisation as a consultant until a new CFO has been recruited and hired.
Bowen served as the Company's CFO from December 2008 to July 2015, during a period of substantial growth for the Company and advised the Company in a consulting role for 1 year following his retirement.
Ian McLeod, Company VP and Corporate Controller, will perform the functions of principal financial officer and principal accounting officer on an interim basis until a permanent CFO has been hired.
McLeod has been employed at the Company for the last 10 years and has served as an outstanding Corporate Controller during this period.
Michael Minogue, Chairman, President and CEO at Abiomed, said: “We wish Mike Tomsicek all the best as he explores other opportunities and thank him for maintaining high standards of financial compliance and quality. We also welcome back Bob Bowen, who has been instrumental to Abiomed's success over nearly the last decade."
